Rs 3568 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Orofer FCM Injection contains Ferric carboxymaltose to treat iron deficiency anemia. It works by releasing iron for hemoglobin synthesis, increasing red blood cell count. Common side effects include headache and nausea. Consult a healthcare professional before use, especially if you have kidney, liver conditions, or are pregnant or breastfeeding.
Active Ingredient: Ferric carboxymaltose Uses: Manages iron deficiency anemia in adults and children over 14. Mechanism: Releases iron from the complex to aid in hemoglobin synthesis and increase red blood cell count. Common Side Effects: Headache, dizziness, flushing, high blood pressure, nausea, injection site reactions. Precautions: Use with caution in patients with kidney, liver issues, or severe asthma. Consult a doctor if pregnant or breastfeeding.
OROFER FCM INJECTION contains iron (III) hydroxide complexed with a carbohydrate polymer called carboxymaltose, which releases iron. The iron released from this complex aids in the synthesis of haemoglobin and boosts the red blood cell count, effectively managing iron-deficiency anaemia.
OROFER FCM INJECTION will be administered to you by a doctor or nurse directly into a vein as an intravenous injection or infusion. Your physician will determine the appropriate dose and duration based on your age, body weight, and the severity of your condition.
ALLERGY CONTRAINDICATED: Do not receive OROFER FCM INJECTION if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine or if you have experienced serious allergic reactions to other injectable iron preparations. PREGNANCY MONITORING REQUIRED: OROFER FCM INJECTION should be used with caution in pregnant women only if considered clearly necessary. Inform your doctor if you are pregnant, think you may be pregnant, or are planning to have a baby. Consult your doctor before receiving the OROFER FCM INJECTION. BREASTFEEDING USE WITH CAUTION: If you are breastfeeding, consult your doctor for advice before receiving an OROFER FCM INJECTION. It is unlikely that an OROFER FCM INJECTION represents a risk to a breast-fed child. KIDNEY USE WITH CAUTION: OROFER FCM INJECTION should be used with caution in patients with chronic kidney disease who are dependent on haemodialysis. Consult your doctor before receiving the OROFER FCM INJECTION. LIVER USE WITH CAUTION: OROFER FCM INJECTION should be used with caution in patients with liver disease. Before receiving OROFER FCM INJECTION, consult with your doctor. LUNGS USE WITH CAUTION: OROFER FCM INJECTION should be used with caution in patients with severe asthma. Consult your doctor before receiving the OROFER FCM INJECTION. USE IN PEDIATRICS CONTRAINDICATED: OROFER FCM INJECTION is not recommended for use in children (under 14 years of age). Consult the child's doctor for advice on how to manage the condition. USE IN GERIATRICS USE WITH CAUTION: OROFER FCM INJECTION should be used with caution in elderly patients (aged 65 years or older). Consult your doctor before receiving the OROFER FCM INJECTION. DRIVING AND USING MACHINES SAFE: OROFER FCM INJECTION is unlikely to impair the ability to drive or operate machines.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s